BACKGROUND AND PURPOSE: CNS complications are often seen after heart surgery, and postsurgical disruption of the BBB may play an etiologic role. The objective of this study was to determine the prevalence of MR imaging-detected BBB disruption (HARM) and DWI lesions after cardiac surgery. MATERIALS AND METHODS: All patients had an MRI after cardiac surgery. For half the patients (group 1), we administered gadolinium 24 hours after surgery and obtained high-resolution DWI and FLAIR images 24-48 hours later. We administered gadolinium to the other half (group 2) at the time of the postoperative scan, 2-4 days after surgery. Two stroke neurologists evaluated the images. RESULTS: Of the 19 patients we studied, none had clinical evidence of a stroke or delirium at the time of the gadolinium administration or the scan, but 9 patients (47%) had HARM (67% in group 1; 30% in group 2; P = .18) and 14 patients (74%) had DWI lesions (70% in group 1; 78% in group 2; P = 1.0). Not all patients with DWI lesions had HARM, and not all patients with HARM had DWI lesions (P = .56). CONCLUSIONS: Almost half the patients undergoing cardiac surgery have evidence of HARM, and three-quarters have acute lesions on DWI after surgery. BBB disruption is more prevalent in the first 24 hours after surgery. These findings suggest that MR imaging can be used as an imaging biomarker to assess therapies that may protect the BBB in patients undergoing heart surgery.
BACKGROUND AND PURPOSE: CNS complications are often seen after heart surgery, and postsurgical disruption of the BBB may play an etiologic role. The objective of this study was to determine the prevalence of MR imaging-detected BBB disruption (HARM) and DWI lesions after cardiac surgery. MATERIALS AND METHODS: All patients had an MRI after cardiac surgery. For half the patients (group 1), we administered gadolinium 24 hours after surgery and obtained high-resolution DWI and FLAIR images 24-48 hours later. We administered gadolinium to the other half (group 2) at the time of the postoperative scan, 2-4 days after surgery. Two stroke neurologists evaluated the images. RESULTS: Of the 19 patients we studied, none had clinical evidence of a stroke or delirium at the time of the gadolinium administration or the scan, but 9 patients (47%) had HARM (67% in group 1; 30% in group 2; P = .18) and 14 patients (74%) had DWI lesions (70% in group 1; 78% in group 2; P = 1.0). Not all patients with DWI lesions had HARM, and not all patients with HARM had DWI lesions (P = .56). CONCLUSIONS: Almost half the patients undergoing cardiac surgery have evidence of HARM, and three-quarters have acute lesions on DWI after surgery. BBB disruption is more prevalent in the first 24 hours after surgery. These findings suggest that MR imaging can be used as an imaging biomarker to assess therapies that may protect the BBB in patients undergoing heart surgery.
Authors: Lucas Restrepo; Robert J Wityk; Maura A Grega; Lou Borowicz; Peter B Barker; Michael A Jacobs; Norman J Beauchamp; Argye E Hillis; Guy M McKhann Journal: Stroke Date: 2002-12 Impact factor: 7.914
Authors: E Michel; H Liu; K B Remley; A J Martin; M T Madison; J Kucharczyk; C L Truwit Journal: AJNR Am J Neuroradiol Date: 2001-09 Impact factor: 3.825
Authors: José Alvarez-Sabín; Pilar Delgado; Sònia Abilleira; Carlos A Molina; Juan Arenillas; Marc Ribó; Esteban Santamarina; Manolo Quintana; Jasone Monasterio; Joan Montaner Journal: Stroke Date: 2004-04-15 Impact factor: 7.914
Authors: Stephan C Knipp; Nadine Matatko; Hans Wilhelm; Marc Schlamann; Parwis Massoudy; Michael Forsting; Hans Christian Diener; Heinz Jakob Journal: Eur J Cardiothorac Surg Date: 2004-05 Impact factor: 4.191
Authors: Yoshimi Anzai; Makiko Ishikawa; Dennis W W Shaw; Alan Artru; Vasily Yarnykh; Kenneth R Maravilla Journal: AJNR Am J Neuroradiol Date: 2004-02 Impact factor: 3.825
Authors: Miles Berger; Niccolò Terrando; S Kendall Smith; Jeffrey N Browndyke; Mark F Newman; Joseph P Mathew Journal: Anesthesiology Date: 2018-10 Impact factor: 7.892
Authors: W M Freeze; D N Ter Weele; W M Palm; R W van Hooren; E I Hoff; J F A Jansen; H I L Jacobs; F R Verhey; W H Backes Journal: AJNR Am J Neuroradiol Date: 2019-08-08 Impact factor: 3.825
Authors: Joseph P Mathew; William D White; David B Schinderle; Mihai V Podgoreanu; Miles Berger; Carmelo A Milano; Daniel T Laskowitz; Mark Stafford-Smith; James A Blumenthal; Mark F Newman Journal: Stroke Date: 2013-10-08 Impact factor: 7.914
Authors: Rebecca Y Klinger; Olga G James; Salvador Borges-Neto; Tiffany Bisanar; Yi-Ju Li; Wenjing Qi; Miles Berger; Niccolò Terrando; Mark F Newman; P Murali Doraiswamy; Joseph P Mathew Journal: Anesthesiology Date: 2018-04 Impact factor: 7.892
Authors: David L McDonagh; Miles Berger; Joseph P Mathew; Carmelo Graffagnino; Carmelo A Milano; Mark F Newman Journal: Lancet Neurol Date: 2014-04-02 Impact factor: 44.182